Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Step-rate cut-points for physical activity intensity in patients with multiple sclerosis: The effect of disability status.
Neuromyelitis Optica Spectrum Disorders.
β-defensin-2 is a responsive biomarker of IL-17A-driven skin pathology in psoriasis.
Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis.
Dilutional Hyponatremia during Hysteroscpic Surgery: Prevention and Treatment.
A neurophysiological study of facial numbness in multiple sclerosis: Integration with clinical data and imaging findings.
Lumican negatively controls the pathogenicity of murine encephalitic TH17 cells.
Cooccurrence of Multiple Sclerosis and Idiopathic Basal Ganglia Calcification.
GDNF Enhances Therapeutic Efficiency of Neural Stem Cells-Based Therapy in Chronic Experimental Allergic Encephalomyelitis in Rat.
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.
Corrigendum to "Expression of DNA methylation genes in secondary progressive multiple sclerosis" [J. Neuroimmunol. 290 (2016 Jan. 15) 66-9].
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis.
Age-related changes in the function and structure of the peripheral sensory pathway in mice.
Melatonin reverses H-89 induced spatial memory deficit: Involvement of oxidative stress and mitochondrial function.
Brain health: time matters in multiple sclerosis.
Comparison of Percutaneous Retrogasserian Balloon Compression and Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Multiple Sclerosis.
SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome.
Anterior disco-osteo-arterial conflict as a cause of intersegmental arterial flow impairment and spinal cord ischemia.
Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model.
Autoimmune Myopathies: Where Do We Stand?
Neurodegeneration in MS and NMO: The Eye and the Blood.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
Pages
« first
‹ previous
…
755
756
757
758
759
760
761
762
763
…
next ›
last »